302 related articles for article (PubMed ID: 1710935)
21. Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat.
Kamizuru H; Kimura H; Yasukawa T; Tabata Y; Honda Y; Ogura Y
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2664-72. PubMed ID: 11581214
[TBL] [Abstract][Full Text] [Related]
22. Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates.
Oseroff AR; Ohuoha D; Hasan T; Bommer JC; Yarmush ML
Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8744-8. PubMed ID: 2877461
[TBL] [Abstract][Full Text] [Related]
23. A carbohydrate-directed heterobifunctional cross-linking reagent for the synthesis of immunoconjugates.
Zara JJ; Wood RD; Boon P; Kim CH; Pomato N; Bredehorst R; Vogel CW
Anal Biochem; 1991 Apr; 194(1):156-62. PubMed ID: 1867379
[TBL] [Abstract][Full Text] [Related]
24. Preparation and characterization of conjugates of monoclonal antibodies and staphylococcal enterotoxin A using a new hydrophilic cross-linker.
Akerblom E; Dohlsten M; Brynö C; Mastej M; Steringer I; Hedlund G; Lando P; Kalland T
Bioconjug Chem; 1993; 4(6):455-66. PubMed ID: 8305515
[TBL] [Abstract][Full Text] [Related]
25. In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen.
Smith-Jones PM; Vallabahajosula S; Goldsmith SJ; Navarro V; Hunter CJ; Bastidas D; Bander NH
Cancer Res; 2000 Sep; 60(18):5237-43. PubMed ID: 11016653
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a novel modification to monoclonal antibodies: thioether cross-link of heavy and light chains.
Tous GI; Wei Z; Feng J; Bilbulian S; Bowen S; Smith J; Strouse R; McGeehan P; Casas-Finet J; Schenerman MA
Anal Chem; 2005 May; 77(9):2675-82. PubMed ID: 15859580
[TBL] [Abstract][Full Text] [Related]
27. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels.
Shockley TR; Lin K; Sung C; Nagy JA; Tompkins RG; Dedrick RL; Dvorak HF; Yarmush ML
Cancer Res; 1992 Jan; 52(2):357-66. PubMed ID: 1728407
[TBL] [Abstract][Full Text] [Related]
28. (6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin.
Willner D; Trail PA; Hofstead SJ; King HD; Lasch SJ; Braslawsky GR; Greenfield RS; Kaneko T; Firestone RA
Bioconjug Chem; 1993; 4(6):521-7. PubMed ID: 7508268
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the colorectal carcinoma-associated antigen defined by monoclonal antibody D612.
Fernsten PD; Primus FJ; Greiner JW; Simpson JF; Schlom J
Cancer Res; 1991 Feb; 51(3):926-34. PubMed ID: 1988133
[TBL] [Abstract][Full Text] [Related]
30. Variable region cDNA sequences and antigen binding specificity of mouse monoclonal antibodies to isomaltosyl oligosaccharides coupled to proteins. T-dependent analogues of alpha(1----6)dextran.
Matsuda T; Kabat EA
J Immunol; 1989 Feb; 142(3):863-70. PubMed ID: 2464028
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of platelet activation by a stimulatory antibody: cross-linking of a novel platelet receptor for monoclonal antibody F11 with the Fc gamma RII receptor.
Naik UP; Ehrlich YH; Kornecki E
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):155-62. PubMed ID: 7646439
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and in vitro evaluation of dipeptide-based antibody minor groove binder conjugates.
Jeffrey SC; Torgov MY; Andreyka JB; Boddington L; Cerveny CG; Denny WA; Gordon KA; Gustin D; Haugen J; Kline T; Nguyen MT; Senter PD
J Med Chem; 2005 Mar; 48(5):1344-58. PubMed ID: 15743178
[TBL] [Abstract][Full Text] [Related]
33. A novel IFN-gamma regulated human melanoma associated antigen gp33-38 defined by monoclonal antibody Me14/D12. I. Identification and immunochemical characterization.
Giuffré L; Isler P; Mach JP; Carrel S
J Immunol; 1988 Sep; 141(6):2072-8. PubMed ID: 3139751
[TBL] [Abstract][Full Text] [Related]
34. Enhanced binding to antigen of monoclonal antibodies modified with a crosslinker.
Ueno H; Masuko T; Wang J; Hashimoto Y
Biochem Biophys Res Commun; 1993 Mar; 191(2):701-8. PubMed ID: 8096384
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibody conjugates of doxorubicin prepared with branched peptide linkers: inhibition of aggregation by methoxytriethyleneglycol chains.
King HD; Dubowchik GM; Mastalerz H; Willner D; Hofstead SJ; Firestone RA; Lasch SJ; Trail PA
J Med Chem; 2002 Sep; 45(19):4336-43. PubMed ID: 12213074
[TBL] [Abstract][Full Text] [Related]
36. Doxorubicin conjugates of monoclonal antibodies to hepatoma-associated antigens.
Shouval D; Adler R; Wands JR; Hurwitz E; Isselbacher KJ; Sela M
Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8276-80. PubMed ID: 2460865
[TBL] [Abstract][Full Text] [Related]
37. Protein conjugates of defined structure: synthesis and use of a new carrier molecule.
Vilaseca LA; Rose K; Werlen R; Meunier A; Offord RE; Nichols CL; Scott WL
Bioconjug Chem; 1993; 4(6):515-20. PubMed ID: 8305521
[TBL] [Abstract][Full Text] [Related]
38. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development.
Karacay H; Sharkey RM; Govindan SV; McBride WJ; Goldenberg DM; Hansen HJ; Griffiths GL
Bioconjug Chem; 1997; 8(4):585-94. PubMed ID: 9258459
[TBL] [Abstract][Full Text] [Related]
39. Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles.
Cirstoiu-Hapca A; Bossy-Nobs L; Buchegger F; Gurny R; Delie F
Int J Pharm; 2007 Mar; 331(2):190-6. PubMed ID: 17196347
[TBL] [Abstract][Full Text] [Related]
40. The impact of trisulfide modification of antibodies on the properties of antibody-drug conjugates manufactured using thiol chemistry.
Liu R; Chen X; Dushime J; Bogalhas M; Lazar AC; Ryll T; Wang L
MAbs; 2017 Apr; 9(3):490-497. PubMed ID: 28136017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
